Cargando...
Antiresorptive agents' bone‐protective and adjuvant effects in postmenopausal women with early breast cancer
Potent antiresorptive drugs (bisphosphonate and denosumab) are often used to protect bone health in postmenopausal breast cancer patients. In addition, clinical trials have shown that these drugs increase disease‐free survival, though the mechanism of adjuvant benefit is largely unknown. Here we rev...
Gardado en:
| Publicado en: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533425/ https://ncbi.nlm.nih.gov/pubmed/30536446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13834 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|